Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Cytoreduction Plus Low-Dose Aspirin Versus Cytoreduction in Monotherapy As Primary Prophylaxis of Thrombosis in Patients with Essential Thrombocythemia.

Alberto Alvarez-Larrán, Arturo Pereira, MD. PhD, Eduardo Arellano-Rodrigo, MD, PhD, Juan Carlos Hernández-Boluda, Francisco Cervantes, MD, Carlos Besses, MD, PhD

Blood (2012) 120 (21): 2828.

https://doi.org/10.1182/blood.V120.21.2828.2828

Published: 2012

Journal Articles

Clinical Evaluation of the European LeukemiaNet Criteria for Resistance/Intolerance to Hydroxyurea In Essential Thrombocythemia

Carles Besses, Alberto Alvarez-Larrán, Montserrat Gómez, Anna Angona, Paula Amat, Beatriz Bellosillo, Luz Martínez-Avilés, Blanca Navarro, Ana Isabel Teruel, Francisco Martínez-Ruiz, Juan Carlos Hernández-Boluda

Blood (2010) 116 (21): 4086.

https://doi.org/10.1182/blood.V116.21.4086.4086

Published: 2010

Journal Articles

Early Optimization of Imatinib Therapy in Patients Newly Diagnosed with Chronic-Phase Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group.

Francisco Cervantes, Pilar López-Garrido, María-Isabel Montero, Fermín Jonte, Jesus Martinez, Juan-Carlos Hernández-Boluda, MD, PhD, María Calbacho, Anna Sureda, MD, PhD, Gloria Pérez-Rus, José Nieto, MD, Cristina Pérez-López, José Román, Marcos González, Arturo Pereira, Dolors Colomer

Blood (2009) 114 (22): 1113.

https://doi.org/10.1182/blood.V114.22.1113.1113

Published: 2009

Journal Articles

Platelet Antiaggregant Therapy Prevents Venous Thrombosis in Patients with JAK2 V617F Positive Essential Thrombocythemia without Indication of Cytoreductive Treatment.

Alberto Alvarez-Larrán, Francisco Cervantes, Eduardo Arellano-Rodrigo, Virginia Pérez-Andreu, Juan-Carlos Hernández-Boluda, Carlos Salvador, Ramón Ayats, Anna Muntañola, Beatriz Bellosillo, Vicente Vicente, Carmen Burgaleta, Anna Gaya, Luis Hernández-Nieto, Blanca Xicoy, Carlos Besses

Blood (2009) 114 (22): 3906.

https://doi.org/10.1182/blood.V114.22.3906.3906

Published: 2009

Journal Articles

JAK2 Mutations at Exon 12 and 14 in Polycythemia Vera and Idiopathic Erythrocytosis: Incidence and Correlation with Clinical Characteristics.

Carlos Besses, MD, PhD, Luz Martínez-Avilés, Alberto Alvarez-Larrán, MD, Francisco Cervantes, MD, PhD, Juan Carlos Hernández-Boluda, MD, PhD, Dolors Colomer, PhD, Lourdes Florensa, MD, PhD, Sergi Serrano, MD, PhD, Beatriz Bellosillo, PhD

Blood (2007) 110 (11): 2532.

https://doi.org/10.1182/blood.V110.11.2532.2532

Published: 2007

Journal Articles

Allogeneic transplantation of CD34 + selected cells from peripheral blood from human leukocyte antigen–identical siblings: detrimental effect of a high number of donor CD34 + cells?

Alvaro Urbano-Ispizua, Enric Carreras, Pedro Marı́n, Montserrat Rovira, Carmen Martı́nez, Francesc Fernández-Avilés, Blanca Xicoy, Juan-Carlos Hernández-Boluda, Emili Montserrat

Blood (2001) 98 (8): 2352–2357.

https://doi.org/10.1182/blood.V98.8.2352

Published: 2001

NARROW

Cytoreduction Plus Low-Dose Aspirin Versus Cytoreduction in Monotherapy As Primary Prophylaxis of Thrombosis in Patients with Essential Thrombocythemia.

Clinical Evaluation of the European LeukemiaNet Criteria for Resistance/Intolerance to Hydroxyurea In Essential Thrombocythemia

Early Optimization of Imatinib Therapy in Patients Newly Diagnosed with Chronic-Phase Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group.

Platelet Antiaggregant Therapy Prevents Venous Thrombosis in Patients with JAK2 V617F Positive Essential Thrombocythemia without Indication of Cytoreductive Treatment.

JAK2 Mutations at Exon 12 and 14 in Polycythemia Vera and Idiopathic Erythrocytosis: Incidence and Correlation with Clinical Characteristics.

Allogeneic transplantation of CD34 + selected cells from peripheral blood from human leukocyte antigen–identical siblings: detrimental effect of a high number of donor CD34 + cells?

Email alerts

ASH Publications

American Society of Hematology

Cytoreduction Plus Low-Dose Aspirin Versus Cytoreduction in Monotherapy As Primary Prophylaxis of Thrombosis in Patients with Essential Thrombocythemia.

Clinical Evaluation of the European LeukemiaNet Criteria for Resistance/Intolerance to Hydroxyurea In Essential Thrombocythemia

Early Optimization of Imatinib Therapy in Patients Newly Diagnosed with Chronic-Phase Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group.

Platelet Antiaggregant Therapy Prevents Venous Thrombosis in Patients with JAK2 V617F Positive Essential Thrombocythemia without Indication of Cytoreductive Treatment.

JAK2 Mutations at Exon 12 and 14 in Polycythemia Vera and Idiopathic Erythrocytosis: Incidence and Correlation with Clinical Characteristics.

Allogeneic transplantation of CD34 + selected cells from peripheral blood from human leukocyte antigen–identical siblings: detrimental effect of a high number of donor CD34 + cells?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only